Authors: VALIQUETT T HUANG S GHAZZI M

Citation: T. Valiquett et al., TROGLITAZONE MONOTHERAPY - LONG-TERM EFFICACY IN PATIENTS WITH TYPE-2DIABETES, Diabetes, 47, 1998, pp. 68-68

Authors: DRAZNIN B DRISCOLL J SIEVERS J VENABLE T GHAZZI M

Citation: B. Draznin et al., TROGLITAZONE PLUS SULFONYLUREA COMBINATION - LONG-TERM EFFICACY IN PATIENTS WITH TYPE-2 DIABETES, Diabetes, 47, 1998, pp. 330-330

Authors: MIDGLEY AR MCFADDEN K GHAZZI M KARSCH FJ BROWN MB MAUGER DT PADMANABHAN V

Citation: Ar. Midgley et al., NONCLASSICAL SECRETORY DYNAMICS OF LH REVEALED BY HYPOTHALAMOHYPOPHYSEAL PORTAL SAMPLING OF SHEEP, Endocrine, 6(2), 1997, pp. 133-143

Authors: GHAZZI M RADKEMITCHELL L VENABLE T WHITCOMB R

Citation: M. Ghazzi et al., TROGLITAZONE IMPROVES GLYCEMIC CONTROL IN PATIENTS WITH TYPE-II DIABETES WHO ARE NOT OPTIMALLY CONTROLLED ON SULFONYLUREA, Diabetes, 46, 1997, pp. 169-169

Authors: DRISCOLL J GHAZZI M PEREZ J HUANG SL WHITCOMB R

Citation: J. Driscoll et al., A 96-WEEK FOLLOW-UP ON CARDIAC SAFETY IN PATIENTS WITH TYPE-II DIABETES TREATED WITH TROGLITAZONE, Diabetes, 46, 1997, pp. 574-574

Authors: GHAZZI M BALAGTAS C PEREZ J WHITCOMB R

Citation: M. Ghazzi et al., TREATMENT OF NIDDM PATIENTS WITH TROGLITAZONE IS NOT ASSOCIATED WITH INCREASED CARDIAC MASS OR IMPAIRED CARDIAC-FUNCTION, Diabetes, 44, 1995, pp. 157-157